NCT06129656 Cardiac Amyloidosis Registry of University Hospital Leipzig
| NCT ID | NCT06129656 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Leipzig |
| Condition | Cardiac Amyloidosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2033-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-05-01 with a primary completion date of 2033-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
Eligibility Criteria
Inclusion Criteria: * Confirmed cardiac amyloidosis according to current standards Exclusion Criteria: * refusal to participate
Contact & Investigator
Daniel Lavall, MD
PRINCIPAL INVESTIGATOR
University of Leipzig
Frequently Asked Questions
Who can join the NCT06129656 clinical trial?
This trial is open to participants of all sexes, studying Cardiac Amyloidosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06129656 currently recruiting?
Yes, NCT06129656 is actively recruiting participants. Contact the research team at daniel.lavall@medizin.uni-leipzig.de for enrollment information.
Where is the NCT06129656 trial being conducted?
This trial is being conducted at Leipzig, Germany.
Who is sponsoring the NCT06129656 clinical trial?
NCT06129656 is sponsored by University of Leipzig. The principal investigator is Daniel Lavall, MD at University of Leipzig. The trial plans to enroll 500 participants.